Miach Orthopaedics has announced that Michael J McNulty has joined the company as vice president of sales and marketing. According to a press release, McNulty will lead Miach’s commercialisation and sales efforts for the Bridge-Enhanced ACL Repair (BEAR) Implant—an investigational device designed for anterior cruciate ligament repair.
McNulty brings more than 20 years of global medical device commercial experience at both large and small companies. Most recently, McNulty served as senior director of sales in the Biologics Division at Smith & Nephew following the company’s acquisition of Rotation Medical, where he served as vice president of sales and marketing. Under his commercial leadership, sales of the bioinductive implant for rotator cuff repair outperformed expectations at both Rotation Medical and Smith & Nephew.
Previously, McNulty served as vice president of sales for Arstasis, where he was responsible for market development, commercial launch, sales training and sales management. He has also held multiple roles at Cordis, a Johnson & Johnson Company, where he helped launch several disruptive technologies to the market and led sales training and sales management for both the Cardiology and Endovascular divisions. McNulty served as an officer in the Armor Cavalry Branch of the United States Army from 1995 to 1998. He holds a Bachelor of Arts degree and graduated with honours from Clemson University.
Martha Shadan, president and CEO, Miach Orthopaedics, comments: “Mike is a talented commercial leader who is skilled at hiring, developing and motivating his team to consistently deliver exceptional sales performance. We have worked together in the past to build a successful business based around a totally new orthopaedic treatment, and I look forward to partnering with him to leverage our experience as we begin planning for the launch of the BEAR Implant.”